Research for a life without cancer
At the DKFZ, we want to ensure that fewer people develop cancer, that cancer can be cured or treated so effectively that those affected can live with the disease and grow old with a good quality of life.
About DKFZ
Latest from DKFZ
Julius Michel, a postdoctoral researcher at the German Cancer Research Center (DKFZ), has received two awards: the Craig Tendler Award for Myeloma Research from the American Society of Hematology - awarded for the first time and accompanied by a $10,000 prize - as well as another award from the society. He has discovered that a modern antibody therapy for multiple myeloma transforms - of all things - the very immune cells that normally suppress the immune system into cancer cell killers.